| Paul Hudson | |
|---|---|
 Hudson in 2023 | |
| Born | (1967-10-14)14 October 1967 |
| Nationality | British |
| Education | Manchester Metropolitan University |
| Title | CEO, Sanofi |
| Term | September 2019- |
| Predecessor | Olivier Brandicourt |
| Children | 3 |
Paul Hudson (born 14 October 1967) is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales.
Early life
Hudson earned a degree in economics from Manchester Metropolitan University, and a diploma in marketing from the Chartered Institute of Marketing.
Career
Hudson has been CEO of Sanofi since September 2019.
Hudson was previously CEO of Novartis Pharmaceuticals, and before that AstraZeneca, rising to president, AstraZeneca United States and Executive Vice President, North America.
Recognition
Hudson was awarded an honorary doctorate by Manchester Metropolitan University in 2018.
Personal life
Hudson has three children with his wife Sandra and is an "ardent Manchester United football fan".
References
- ^ "Paul Hudson - Sanofi". www.sanofi.com.
- "Paul Hudson - Sanofi". www.sanofi.com. Retrieved 29 January 2021.
- Willsher, Kim (26 January 2021). "French self-esteem hit after Pasteur Institute abandons Covid vaccine" – via www.theguardian.com.
- "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune.
- "Sanofi's CEO on a big acquisition, long-term strategy, and vaccines". 17 August 2020.
- ^ "Global Proof of Concept: Q&A with Paul Hudson | Thought Leadership". Russell Reynolds Associates. Archived from the original on 24 February 2021. Retrieved 26 January 2021.
- "AstraZeneca announces changes to Senior Executive Team". Fiercepharma.
- "Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints leaders to the Executive Committee of Novartis". Novartis. Retrieved 24 April 2023.
- "Paul Hudson". Manchester Metropolitan University. Retrieved 24 April 2023.
| Business positions | ||
|---|---|---|
| Preceded byOlivier Brandicourt | CEO of Sanofi 2019–present |
Succeeded byIncumbent |
| Sanofi | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Predecessors | |||||||||||||
| CEOs | |||||||||||||
| Main products |
| ||||||||||||
| Subsidiaries |
| ||||||||||||